Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1851
WisdomTree US LargeCap Fund
EPS
$1.67B
| $72.3M | ﹤0.01% |
928,869
+39,193
| +4% | +$2.97M |
2013 Q2
52 quarters
|
|
1852
Lithia Motors
LAD
$6.39B
| $72.1M | ﹤0.01% |
248,365
+75,680
| +44% | +$21.5M |
2013 Q2
52 quarters
|
|
1853
Primerica
PRI
$8.54B
| $72.1M | ﹤0.01% |
253,857
+39,158
| +18% | +$10.7M |
2013 Q2
52 quarters
|
|
1854
DELISTED
Xoma
XOMA
| $72.1M | ﹤0.01% |
1,697,167
-4,990
| -0.3% | -$202K |
2013 Q2
52 quarters
|
|
1855
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.74B
| $72.1M | ﹤0.01% |
1,265,333
+21,047
| +2% | +$1.17M |
2013 Q2
52 quarters
|
|
1856
Relay Therapeutics
RLAY
$4.13B
| $72.1M | ﹤0.01% |
3,851,071
+2,419,068
| +169% | +$35.1M |
2020 Q3
23 quarters
|
|
1857
iShares High Yield Muni Active ETF
HIMU
$2.53B
| $72M | ﹤0.01% |
1,446,412
+157,391
| +12% | +$7.68M |
2025 Q1
5 quarters
|
|
1858
IDEAYA Biosciences
IDYA
$3.23B
| $72M | ﹤0.01% |
1,931,491
+71,038
| +4% | +$2.17M |
2019 Q4
26 quarters
|
|
1859
Icon
ICLR
$14.1B
| $71.9M | ﹤0.01% |
414,192
+121,050
| +41% | +$15.4M |
2013 Q2
52 quarters
|
|
1860
Cohen & Steers Quality Income Realty Fund
RQI
$1.53B
| $71.9M | ﹤0.01% |
5,843,742
+399,563
| +7% | +$5.18M |
2013 Q2
52 quarters
|
|
1861
OneMain Financial
OMF
$6.54B
| $71.9M | ﹤0.01% |
1,179,030
+256,105
| +28% | +$14.4M |
2013 Q4
50 quarters
|
|
1862
Invesco International Dividend Achievers ETF
PID
$878M
| $71.8M | ﹤0.01% |
3,235,994
+52,828
| +2% | +$1.2M |
2013 Q2
52 quarters
|
|
1863
iShares MSCI Australia ETF
EWA
$1.25B
| $71.7M | ﹤0.01% |
2,547,110
-164,492
| -6% | -$4.77M |
2013 Q2
52 quarters
|
|
1864
Radian Group
RDN
$4.72B
| $71.7M | ﹤0.01% |
1,903,708
+383,215
| +25% | +$13.6M |
2013 Q2
52 quarters
|
|
1865
iShares US Transportation ETF
IYT
$1.96B
| $71.7M | ﹤0.01% |
826,646
-824,096
| -50% | -$67.4M |
2013 Q2
52 quarters
|
|
1866
Allied Gold Corp
AAUC
$2.83B
| $71.7M | ﹤0.01% |
3,013,200
-758,158
| -20% | -$21.4M |
2025 Q2
4 quarters
|
|
1867
Korn Ferry
KFY
$4.26B
| $71.5M | ﹤0.01% |
1,073,988
+134,685
| +14% | +$9.11M |
2013 Q2
52 quarters
|
|
1868
Sonoco
SON
$4.87B
| $71.5M | ﹤0.01% |
1,268,448
+457,773
| +56% | +$23.5M |
2013 Q2
52 quarters
|
|
1869
Exponent
EXPO
$3.63B
| $71.3M | ﹤0.01% |
1,214,003
+141,995
| +13% | +$8.71M |
2013 Q2
52 quarters
|
|
1870
Vista Energy
VIST
$7.91B
| $71.3M | ﹤0.01% |
1,117,572
-110,189
| -9% | -$7.76M |
2019 Q3
27 quarters
|
|
|
MRX
1871
Marex Group Limited Ordinary Shares
MRX
$5B
| $71.3M | ﹤0.01% |
1,169,722
+692,424
| +145% | +$38.1M |
2024 Q2
8 quarters
|
|
1872
American Century Diversified Corporate Bond ETF
KORP
$960M
| $71.3M | ﹤0.01% |
1,521,596
-83,429
| -5% | -$3.9M |
2020 Q2
24 quarters
|
|
1873
ALPS Sector Dividend Dogs ETF
SDOG
$1.44B
| $71.3M | ﹤0.01% |
1,044,484
-4,342
| -0.4% | -$291K |
2013 Q2
52 quarters
|
|
1874
ProShares Large Cap Core Plus
CSM
$554M
| $71.2M | ﹤0.01% |
835,854
+11,156
| +1% | +$928K |
2013 Q2
52 quarters
|
|
1875
Amneal Pharmaceuticals
AMRX
$7.47B
| $71.1M | ﹤0.01% |
4,110,028
-527,157
| -11% | -$7.22M |
2018 Q2
32 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 302 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 302 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.